Global antimicrobial stewardship and the need for pharmaceutical system strengthening for antimicrobials within a One Health approach.
Int J Pharm Pract
; 30(2): 175-179, 2022 May 26.
Article
in English
| MEDLINE | ID: covidwho-1758744
ABSTRACT
OBJECTIVES:
The COVID-19 pandemic has highlighted both the vulnerabilities and the critical role of global pharmaceutical systems in enabling equitable access to medicines. In this personal view, we position the pharmaceutical system as a missed research and investment opportunity that, if integrated properly, would benefit antimicrobial stewardship (AMS) programmes within a One Health approach. KEYFINDINGS:
The pharmaceutical supply management cycle (PSMC) illustrates the continuous interdependence between four key phases selection, procurement, distribution and use. Furthermore, a PSMC is subject to external forces of market competition, policy and regulation - across human, animal and environmental health. We present examples of overlap in PSMCs across different One Health sectors and discuss the need for integration within human, animal and environmental health contexts.SUMMARY:
Despite pharmaceutical systems being fundamental to successful AMS programmes, they are currently neglected and undervalued. Research and investment into pharmaceutical system optimisation and integration into AMS programmes present an opportunity for both high-income countries and low- and middle-income countries to develop responsible, comparable and international AMS innovations and interventions.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
One Health
/
Antimicrobial Stewardship
/
COVID-19
/
Anti-Infective Agents
Limits:
Animals
/
Humans
Language:
English
Journal:
Int J Pharm Pract
Journal subject:
Pharmacy
Year:
2022
Document Type:
Article
Affiliation country:
Ijpp
Similar
MEDLINE
...
LILACS
LIS